Fecal Profiling May Predict Dietary Response in IBS

Fecal profiling of volatile organic compounds (VOCs) may provide a low cost, non-invasive tool to predict the responses of irritable bowel syndrome (IBS) patients to probiotics and diets low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs), according to British researchers.

Modeling baseline fecal VOCs, and using key features of VOC profiles, correctly predicted response to a low-FODMAP diet in 100% of patients and in 89% of patients receiving a probiotic, reported Megan Rossi, PhD, RD of King’s College in London, and colleagues.

This approach can potentially shed light on the pathophysiology of IBS, and advance its clinical management with more precisely personalized nutrition regimens, they wrote in Clinical Gastroenterology and Hepatology.

Multiple randomized trials have indicated that the low-FODMAP diet is effective in 50%-80% of IBS patients. “However, predicting response is clinically important because the diet requires intensive dietary counselling and impacts on both the gut microbiota and nutrient intake, and, therefore, avoiding this intervention in the 20%-50% who are unlikely to respond would be an important clinical advance,” Rossi’s group noted.

New approaches are definitely needed, according to William D. Chey, MD, of the University of Michigan in Ann Arbor.

“Only about half [of patients] get better on the diet, which has associated shopping costs and inconvenience to the patient, plus input from a dietitian and an extended three-step period of time to work through its stages,” Chey told MedPage Today. “This often gets glossed over but it’s not a trivial thing.”

Chey, who was not involved in the study, further explained that little is known about the long-term nutritional and microbiotic downsides of this restrictive diet. “By excluding prebiotic carbohydrates, you are very likely to have effects on the microbiome, so it’s important to identify strategies that enrich the likelihood of response and maximize choosing the right treatment for the right patient,” he said.

Rossi’s group used data and samples from patients with IBS-diarrhea, IBS-mixed, and IBS-unsubtyped treated at two major London hospitals and participating in a previous clinical trial. A total of 95 patients (majority white), whose age ranged from early to late 30s, completed the study. Of these, 93 (63 women) provided sufficient fecal sample for analysis and were randomized for 4 weeks to a low-FODMAP diet (n=46) or a sham diet plus dietary advice (n=47).

In 2-by-2 factorial fashion, patients in both dietary groups also received either a multi-strain probiotic supplement (n=49) or a placebo supplement (n=44).

Gas chromatography assessed VOCs in fecal samples at baseline and at study completion. The clinical endpoint was the IBS Severity Scoring System (IBS-SSS), which records abdominal pain, distension, stool frequency and consistency, and interference with life over a 10-day period.

All 93 participants were deemed compliant with diet, and 86 were classified as compliant with supplementation. At the end of the study, those in the low-FODMAP arm had a significantly lower total FODMAP intake (20+8 g/day) compared with those on the sham diet (33+16 g/day, P<0.001).

In terms of response, more patients reacted clinically to the low-FODMAP diet (37/46, 80%) than the sham diet (21/47 45%, P<0 .001), with a mean change in IBS-SSS score of –130 and –49 (P<0.001), respectively.

There was no difference in clinical response between patients given the probiotic (31/49, 63%) versus placebo (27/44, 61%, P=0.850), with no synergistic or antagonistic effects observed with supplementation. In addition, there was no difference in the mean change in IBS-SSS score between recipients of probiotic (–88) and placebo (–90, P=0.921).

The researchers found that baseline VOC profiles contained 15 features that explained 25% of response variation to the low-FODMAP diet with a mean accuracy of 97% (95% CI 96%-99%), as well as 10 features that explained 30% of response variation to the probiotic, with a mean accuracy of 89% (95% CI 86%-92%). At end of treatment, nine observed compounds explained 31% of variation in response to low-FODMAP and 11 compounds explained 27% of variation with the probiotic.

As to how VOCs predict response, the authors pointed out that many of these compounds are created from indigestible food substrates in the colon through both microbial metabolic activity and diet. VOC patterns at baseline may reflect the pathophysiology of an individual’s IBS and eating a high-FODMAP standard diet may, in the presence of IBS-associated dysbiosis, generate fermentation products that cause symptoms. Once the normal diet has been replaced, there is less substrate for bacterial metabolism and gas production and associated symptoms are reduced.

Study limitations included the relatively small sample size, its exploratory nature and the lack of data to inform a power calculation. Also, since the device that assessed fecal VOCs identified patterns of VOCs, not individual VOCs, detailed investigation of the potential mechanisms of individual VOCs could not be done. Finally, the 2-by-2 factorial design may have clouded the results.

Chey noted that, in his experience, about half of patients improve on the low-FODMAP diet, a remarkably high rate of success for a dietary therapy. Also, some of his patients have been following a reduced-FODMAP diet since his institution began introduced it in 2008.

“And up to 85% can move to a less restrictive diet after the phase of determining sensitivities,” Chey said.

What You Can Tell About Someone From Their…Earwax

New research shows that earwax varies among people of different ethnicities, suggesting that the substance holds untold secrets.

A team of scientists from Monell Chemical Senses Center in Philadelphia gathered earwax from 16 men–half were white and half were East Asian–and examined the volatile organic compounds (VOCs) they released when heated. The amount of VOCs per person varied by ethnicity, and white men had more overall.

83865341 copy

This small finding is important to researchers who believe earwax may carry attributes specific to each individual. Wet or dry earwax is linked to a gene that is also linked to the production of underarm odor, which can convey information about one’s gender, sexual orientation, and health. Already two urine diseases can be diagnosed in earwax before blood or urine testing.

“Odors in earwax may be able to tell us what a person has eaten and where they have been,” George Preti, an organic chemist at Monell told Medical News Today.

Earwax is “a neglected body secretion,” according to researchers at Monell Chemical Senses Center in Philadelphia, PA. A new study shows that, as well as giving different odors corresponding to ethnic group, earwax could store other other useful personal information.

A mixture of secretions from sweat glands and the fatty byproduct of sebaceous glands, earwax is usually a wet yellow-brown wax or a dry white wax.

This wax makes its way to the opening of the ear and is usually washed away when we have a shower or bath.

But earwax does have some beneficial properties.

It traps and prevents dust, bacteria and small objects from getting inside the ear and damaging it, and it can protect the delicate ear canal from irritation when water is in the canal.

Genetic link between underarm odor and earwax

The Monell Center became interested in the properties of earwax after discovering that variations in a gene known as ABCC11 are related to whether a person has wet or dry earwax. This gene is also linked with underarm odor production.

“Our previous research has shown that underarm odors can convey a great deal of information about an individual, including personal identity, gender, sexual orientation and health status,” says study lead author George Preti, PhD, an organic chemist at Monell. “We think it possible that earwax may contain similar information.”

Earwax is usually a wet yellow-brown wax or a dry white wax produced by sweat and sebaceous glands.

Given that differences in underarm odor can carry this level of personal detail, Preti wanted to see if earwax odor also has characteristics specific to ethnicity.

Preti’s team collected earwax from 16 men – eight of these were white and eight were of East Asian descent. The samples were placed into individual vials that were heated for 30 minutes.

Once heated, the earwax began to release airborne molecules called “volatile organic compounds” (VOCs).

The VOCs – which are odorous – were then collected from the vials using a special absorbent device. A technique called “gas chromatography-mass spectrometry” was used to analyze the chemical make-up of these molecules.

White men produce more odorous earwax than East Asian men

Although 12 different types of VOC were found across all the earwax samples, the amounts of these VOCs seemed to vary according to ethnic background. The white men in the study had greater amounts of 11 of the VOCs than the East Asian men in the study.

East Asian and Native American people were already known to have a form of the ABCC11 gene that causes the dry type of earwax and produces less underarm body order, compared with other ethnicities.

“Odors in earwax may be able to tell us what a person has eaten and where they have been,” says Preti. “Earwax is a neglected body secretion whose potential as an information source has yet to be explored.”

The study notes that at least two odor-producing diseases – maple syrup urine disease and alkaptonuria – can be identified in earwax before they can be detected in blood or urine analyses. Further research from the Center will examine the possibility that analysis of earwax could be useful in detecting conditions before they show up in more traditional tests.

The ABCC11 gene is also associated with breast cancer. In 2009, Japanese scientists found that underarm odor and earwax could alert doctors to women who were carrying this gene and who therefore have increased risk of breast cancer.